These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Platelet function studies in myeloproliferative disorders. Pfliegler G; Boda Z; Udvardy M; Kiss A; Telek B; Pecze K; Nagy P; Rak K Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):655-62. PubMed ID: 2435631 [TBL] [Abstract][Full Text] [Related]
26. Platelet phospholipids in thrombocytosis due to myeloproliferative disorders. Breuer JH; Harsányi V; Solti V; Hollán SR Haemostasis; 1981; 10(3):134-40. PubMed ID: 7262643 [TBL] [Abstract][Full Text] [Related]
27. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders. Yamamoto K; Sekiguchi E; Takatani O Thromb Haemost; 1984 Dec; 52(3):292-6. PubMed ID: 6531753 [TBL] [Abstract][Full Text] [Related]
28. [Classification of chronic psychoses types I and II and platelet serotonin levels. Apropos of 38 cases]. Boudjema F; Terra JL; Guyotat J; Lemoine P; Renaud B; Flachaire E Encephale; 1985; 11(1):39-42. PubMed ID: 3996288 [TBL] [Abstract][Full Text] [Related]
29. Serotonin uptake and efflux in blood platelets from untreated and neuroleptic-treated schizophrenics. Lingjaerde O Biol Psychiatry; 1983 Dec; 18(12):1345-56. PubMed ID: 6140960 [TBL] [Abstract][Full Text] [Related]
30. [Method of determination of bound and free serotonin in different biological media]. Pliushkis Iu; Matulis AA; Murza VA Lab Delo; 1976; (2):84-8. PubMed ID: 58106 [No Abstract] [Full Text] [Related]
31. Platelet and plasma beta thromboglobulin in myeloproliferative syndromes and secondary thrombocytosis. Boughton BJ; Allington MJ; King A Br J Haematol; 1978 Sep; 40(1):125-32. PubMed ID: 81681 [TBL] [Abstract][Full Text] [Related]
34. [Blood platelet function in chronic myeloid-type diseases. I. Myeloproliferative diseases]. Cieslar P; Matousová O Vnitr Lek; 1987 Nov; 33(11):998-1009. PubMed ID: 3439041 [No Abstract] [Full Text] [Related]
35. Serotonin as a factor involved in pathophysiology of thromboangiitis obliterans. Pietraszek MH; Choudhury NA; Baba S; Sakaguchi S; Hachiya T; Urano T; Takada Y; Takada A Int Angiol; 1993 Mar; 12(1):9-12. PubMed ID: 8376917 [TBL] [Abstract][Full Text] [Related]
36. In vivo platelet release in myeloproliferative disorders. Ireland H; Lane DA; Wolff S; Foadi M Thromb Haemost; 1982 Aug; 48(1):41-5. PubMed ID: 6215739 [TBL] [Abstract][Full Text] [Related]
37. Platelet and plasma serotonin concentrations in glomerulonephritis, II. Parbtani A; Frampton G; Cameron JS Clin Nephrol; 1980 Sep; 14(3):112-23. PubMed ID: 7418277 [TBL] [Abstract][Full Text] [Related]
38. Platelet Fc receptor. Increased expression in myeloproliferative disease. Moore A; Nachman RL J Clin Invest; 1981 Apr; 67(4):1064-71. PubMed ID: 6937475 [TBL] [Abstract][Full Text] [Related]
39. Platelet factor-4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis. Burstein SA; Malpass TW; Yee E; Kadin M; Brigden M; Adamson JW; Harker LA Br J Haematol; 1984 Jul; 57(3):383-92. PubMed ID: 6743563 [TBL] [Abstract][Full Text] [Related]
40. Changes in distribution of platelet membrane glycoproteins in patients with myeloproliferative disorders. Bolin RB; Okumura T; Jamieson GA Am J Hematol; 1977; 3():63-71. PubMed ID: 602945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]